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ABSTRACT
International Journal of Exercise Science 14(3): 1004-1017, 2021. This study evaluated plasma levels of

brain-derived neurotropic factor (BDNF), irisin, and lactate in people living with HIV/AIDS who completed a
combined physical training program. Nineteen HIV+ participants (age: 39.60 ± 10.96 years; carrier time: 7.75 ± 7.88
years; time of ART: 6.41 ± 5.93 years) performed strength/aerobic training (combined physical training) in the same
session for 8 weeks and levels of BDNF, irisin, and lactate were assessed. BDNF (pg/mL) was higher post-CPT (Pre:
1258.73 ± 372.30; Post: 1504.17 ± 322.30; p < 0.001). Irisin (ng/mL) showed no change (Pre: 115.61 ± 72.41; Post: 125.87
± 81.14; p = 0.973). There was positive correlation between irisin and lactate (mmol/L) pre (r = 0.55, p = 0.04), and
lactate values were higher in the group with the highest value of irisin (3.65 ± 0.69 x 2.82 ± 0.59, p = 0.02). Combined
physical training results in increased basal BDNF in people living with HIV/AIDS, this finding suggests that
increased concentration of BDNF may be associated with decreased chances of developing cognitive disorders or
HIV-associated dementia. Further studies involving molecular mechanisms on this subject are necessary.
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INTRODUCTION
AIDS is an infection caused by the human immunodeficiency virus (HIV) and is characterized
by the decreased number of circulating TCD4 + lymphocytes, depressing the immune system of
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individuals and predisposing them to the development of opportunistic diseases that, if not
treated, lead to death (1).
Neurocognitive diseases are found in 30% to 50% of people living with HIV/AIDS (PLWHA),
as the virus can cross the blood-brain barrier and infect the cells of glia, inducing damage and
neural death (16). A useful biomarker, and one that perhaps will serve as a control for
neurological changes, is brain-derived neurotrophic factor (BDNF), an important neurotrophin
involved in the development of the parahippocampal region. Neurotrophic factors in general,
have functions of neural regulation and differentiation as well as modulation of plasticity and
survival of neurons and glial cells (29, 40). Several studies have shown that cognitive changes as
well as psychiatric disorders such as depression may decrease the concentration of BDNF in
individuals both infected and not affected by HIV (17, 23, 27). In addition, increases in BDNF
have been shown to be negatively related to depressive symptoms and Alzheimer's disease (26),
leading some researchers to suggest peripheral BDNF as a biomarker of these diseases (18, 31).
Thus, it can serve as an instrument to monitor the HIV-Associated Dementia and neurocognitive
diseases associated with HIV (HAND), for example.
In addition to neurological changes, metabolic disorders are also common in PLWHA and
undergoing Antiretroviral Therapy (ART). The use of nucleotide analogue reverse-transcriptase
inhibitors (NRTIs) is commonly related to the onset of mitochondrial toxicity/dysfunction that
affects several tissues, including the liver and muscles, leading to injury of the oxidative energy
system, a fact that contributes substantially to resting hyperlactatemia and high oxidative stress
(38). This condition indicates a possible mitochondrial dysfunction, which in this case is related
to the inhibition of the enzyme DNA polymerase gamma by NRTIs, a phenomenon that impairs
mitochondrial DNA replication (4).
Currently, it is known that the mitochondrial dysfunction and injury of oxidative
phosphorylation, including reduction of mitochondrial DNA and peroxisome proliferatoractivated receptor-gamma (PPARγ) expression, exert influence on the metabolic homeostasis of
PLWHA, and irisin is one of the molecules affected. Irisin is a protein derived from proteolytic
cleavage of the fibronectin type III domain-containing protein 5 (FNDC5) gene and is secreted
mainly by skeletal muscle and adipose tissue in humans and animals. It is known that the
expression of FNDC5 is increased by the PPARγ activation and by its coactivator peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 α), and may have an effect
from physical exercise (7). However, there is little evidence in the literature about this substance
and its relationship with PLWHA as well as its influence on resting blood lactate levels in this
population (34).
The main function of irisin is to promote energy expenditure through increased activity of
brown adipose tissue (BAT) or the conversion of white adipose tissue (WAT) in beige, which
have molecular characteristics close to BAT (8). This is due to the presence of a higher number
of mitochondria stimulated by uncoupled protein 1 (UCP-1) which, when activated, divert the
protons of the electron transport chain, decreasing the production of energy (ATP) at the
expense of increased body temperature (thermogenesis) (7). Some studies have shown also
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increase in irisin levels in oxidative stress conditions, inflammation and energy production
problems (2, 5, 41), and this condition is present in this population due to the ART use (35).
However, little is known about irisin and PLWHA, since these participants present major
changes in the two main secretory tissues (muscle and fat) of this protein, as decreased muscle
mass and the accumulation of adipose tissue in the abdominal area (30, 34). In addition, no study
analyzes the irisin relation with blood lactate levels (a useful variable to analyze the metabolism
conditions and energy production) in this population.
Interestingly, the secretion of both irisin and BDNF is stimulated by muscle contraction, and
peripheral neural stimulation via PGC1-α/FNDC5 by physical exercise enhances the expression
and secretion of both (39). Some studies have investigated effects from exercise (39) or in specific
populations, such as the elderly (32), Crossfit® athletes (24), endurance athletes (6), and people
with multiple sclerosis (10), and the results are controversial depending on the type of
intervention and/or studied population.
Because the association between HIV infection and ART provokes the increased risk of
metabolic and neurocognitive disorders, as well as the absence of studies that have evaluated
the HIV/AIDS x irisin x BDNF x resting blood lactate interaction response to physical exercises,
the present investigation aimed to evaluate these markers. In addition, a secondary goal was to
examine whether correlations exist among these markers in PLWHA who completed a CPT
program.
METHODS
Participants
A power analysis conducted a priori with G*POWER 3.1 software (Universitat Kiel, Germany).
We based on Cho et al. (12) that aimed to analyze the combined exercise serum BDNF level in
mid-aged women. Using the medium, standard deviation and percentage changes values of
BDNF levels, we observed in this study an effect size of 1.27 and power of 0.97. Based on these
data, effect size and beta power were needed in the present study at least 11 participants as a
minimum sample. In addition, to verify the power of the present sample after the experimental
period/study, we calculated the Post Hoc power also in the G Power 3.1. This calculation was
based on the statistical test used in the study, the "n" obtained from 19 participants, an alpha
significance level of 0.05, an effect size of 0.79 from the pre/post values of the means and
standard deviation of BDNF levels (the main result of the study). As a result, we observed a beta
power of 0.90, up from the normally stipulated 0.80, which is usually used as a minimum
required to characterize a sample as capable of detecting a difference in a given population.
As mentioned, nineteen participants infected with HIV participated in this study (11 women
and 8 men) (age: 39.60 ± 10.96 years; Carrier time: 7.75 ± 7.88 years; Time of ART: 6.41 ± 5.93
years); and were undergoing treatment in specialized service centers, located in the city of
Cuiabá, Mato Grosso, Brazil. The inclusion criteria used were: minimum age of 18 years,
sedentary or inadequately active, have no impediments that would prevent exercising, should
be using ART, and have 85% minimum frequency of the training performed. The patients who
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presented with cardiovascular, cancer and inflammatory diseases, TCD4 + cell counts less than
200 cells/mm3, pregnancy, failed to obtain medical release, or did not complete all stages of
research were excluded. No dietary intervention was performed, the participants were
instructed to maintain food habits prior to the survey.
The research was approved by the Research Ethics Committee of the Júlio Muller Universitary
Hospital, which is linked to the Federal University of Mato Grosso (Protocol No: 673/09) and
was based on the principles of the Declaration of Helsinki. In addition, this research was carried
out fully in accordance to the ethical standards of the International Journal of Exercise Science
(25). All participants provided written informed consent prior to participation. Flow of
participants through the study is shown in the Figure 1.
Figure 1. Flow of participants through the study.

Protocol
The experimental design is described in the figure 2 below.
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Figure 2. Experimental design

Biochemical analysis: All blood sample collections were performed in the morning (08:00-10:00)
after a fast of 12 hours and were completed in two phases. First, for immune profile analysis,
blood was collected at a specialized customer service (SAE), Cuiabá, Mato Grosso, Brazil. The
variables analyzed were: quantification of viral load (method: b-DNA Kit: HIV RNA 3.0); cell
counts for TCD4+, TCD8+, and TCD4+/TCD8 (method: flow cytometry-Facscalibur-multitest).
On another day, the participants went to the Laboratory of Biochemistry, Molecular Biology and
Exercise of Faculty of Physical education, Federal University of Mato Grosso, Cuiabá, Brazil for
another blood sample collection, which was centrifuged and serum stored in a freezer at -80°C
for further analysis of BDNF and irisin. BDNF and irisin were analyzed by ELISA (EnzymeLinked immunosorbent assay test) from commercial kits (R&D System Inc., Minneapolis, MN,
USA and MyBioSource Inc., San Diego, CA, USA, respectively). The minimum detectable dose
was 184.38 pg/mL for BDNF and 27.85 ng/mL for irisin. The coefficient of variation (irisin)
intra- and inter-analysis was 2.9-9.5% and 5.9-7.0%, respectively, and the sensitivity was 0.0093
pg/mL. All samples were determined in duplicate to ensure the accuracy of the results.
The determination of resting blood lactate occurred after adaptation and before the beginning
of the CPT and consisted of two blood collections, which was obtained perforation of the index
finger (Accutrend Plus Lactimeter/BM-Lactate Tests Tapes Roche®-Germany), performed on
two separate days. The value of the final concentration was obtained by the average of the two
collections.
Body composition: An electrical bioimpedance device (Maltron Body Composition Analyzer ®,
Warwick) was used for the measurement of the following variables: relative body fat (%),
relative lean mass (%), body mass index (BMI) and basal metabolic rate (BMR). The participants
were told to not ingest alcohol, not consume food or beverages that contain stimulants, ingest a
minimum quantity of 2 liters of water, as well as urinating up to a maximum of 30 minutes
before the test. On the day of assessment, earrings, chains and/or rings and shoes of the
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participants were removed. Hands and feet were cleansed, and the patients were placed supine
on a pad where electrodes were fixed in the left hand and foot.
Cardiorespiratory fitness: The 2400-meter displacement test was used to determine aerobic
physical training prescription. This test consists of participants walking or running 2400 meters
at the maximum speed possible. Maximal oxygen consumption (Vo2max) was estimated by the
following formula: VO2max = distance/time x 0.2 +3.5 (13).
Muscle strength: The 1 repetition maximum (RM) test was used to evaluate muscle strength of
the participants before and after the CPT, following appropriate recommendations (9). The
participants performed two sessions of adaptation in the bench press, leg press 45°, and biceps
curls, in order to establish the correct execution of the movement. After the adaptation period,
participants performed 1 RM test and re-test on two non-consecutive days (minimum of 72 h
between testing sessions). After 5 minutes of walking on a treadmill at a light intensity (based
on the scale of perceived exertion), the participants performed a specific warm-up of 8
repetitions with 50% of 1 RM (according to previous loads used in the adaptation sessions),
followed by three repetitions at 70% of 1 RM.
Subsequently, repetitions were performed with progressively heavier loads, and the 1 RM was
determined within a maximum of three attempts, using rest intervals of 3 to 5 minutes between
retries. The intraclass correlation (ICC) coefficient was r > 0.96 for the exercises tested,
confirming the reliability test re-test.
For the prescription of resistance training, we used the 10 maximal repetitions (10 RM) test,
which was performed on the following devices: half squat (guided bar), bench press, leg curl,
barbell upright row, leg press 45°, triceps pulley, bending plant, dumbbell press, and biceps
curls, following the adapted recommendations: 1) warm-up for 5 to 10 repetitions at 40 - 60% of
estimated load, followed by a break of 1 minute; 2) execution of 3 to 5 repetitions at 60% of
estimated load and a rest of 3 minutes; 3) load increase, trying to reach the 10 RM in up to five
attempts, with rest between each attempt of up to five minutes. The load changes occurred as
follows: less than 10 repetitions resulted in a reduction of up to 10%; more than two repetitions,
in addition, resulted in increased load in the same proportion. The value registered was that
obtained in the last successful repetition (9). The load of abdominal and plantar flexion exercises
was analyzed through the located muscular resistance test (maximum number of executions per
minute).
Combined Physical Training (CPT): In order to complete familiarization, the participants were
subjected to two weeks of adaptation to the gym´s equipment. The participants included in the
survey obtained 85% minimum frequency in the training performed. Stretching exercises for the
entire body were carried out before and after the training session.
The CPT itself had a total duration of eight weeks and was carried out three times per week
(days interspersed). The resistance training was conducted in a circuit, and the participants
performed a single set on the following equipment: 1/2 squat (guided bar), bench press, leg curl,
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barbell upright row, leg press 45°, triceps pulley, dumbbell press, bending plant and biceps
curls. At the end of the circuit, there was a recovery of 90 seconds. The same sequence was then
repeated, totaling two laps on the circuit. After resistance training was completed, the
participants began aerobic training, which consisted of a walk lasting 30 to 40 minutes (60-70%
of maximal heart rate monitored by a frequency meter). The periodization of CPT is described
in Table 1.
Table 1. Periodization of combined physical training
Resistance Training
Weeks
1ª e 2ª
Circuit (number of rounds)
2
Repetitions
12 a 15
Intensity (%)
60
Aerobic training
Intensity (FCmax [%])
60 a 70
Duration (minutes)
30

3ª e 4ª
2
10 a 12
75

5ª e 6ª
2
8a6
85

7ª e 8ª
2
4a6
100

60 a 70
30

60 a 70
40

60 a 70
40

Statistical Analysis
The analysis of data normality was performed using the Shapiro-Wilk test, and Student's T and
Mann-Whitney tests for parametric and nonparametric data, respectively. To check for
correlations among BDNF, irisin and blood lactate in the moment pre-and between ∆% of change
by training, Pearson correlation test (BDNF and irisin) and Spearman (blood lactate with BDNF
and irisin) were performed. Taking into consideration that our hypothesis relates irisin and
blood lactate and due to the fact that we have found a correlation between these variables at the
moment pre-CPT, a cluster analysis was applied (K-means cluster), using the irisin level values
of each subject. This analysis divided the "19" irisin values into two groups of clusters with the
closest mean (higher [n = 6] and lower [n = 13] levels of irisin). The student's t-test was used to
analyze the differences between blood lactate levels of two groups/clusters. The software used
for all analyses was Statistica (version 6.0). The results were expressed as mean ± standard
deviation and established the significance level of 5%.
RESULTS
Prior to the beginning of the CPT, the viral load of the participants was undetectable (< 50
copies/mL); TCD4+ lymphocytes (630 ± 173 cells/mm3) and TCD8+ (988 ± 522 cells/mm3) were
obtained in desirable values for the safe practice of regular exercise. The table 2 shows the
medications used by the research participants.
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Table 2. Class of drugs used by research participants
Participant
Medicines
Class of medicines
1
Nevirapina, Estavudina, Lamivudina
NNTRs, NRTIs, NRTIs
2
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
3
Ritonavir, Estavudina, Lamivudina, Atazanavir
PIs, NRTIs, NRTIs, PIs
4
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
5
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
6
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
7
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
8
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
9
Nevirapina, Estavudina, Lamivudina
NNTRs, NRTIs, NRTIs
10
Nevirapina, Estavudina, Lamivudina
NNTRs, NRTIs, NRTIs
11
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
12
Nevirapina, Estavudina, Lamivudina
NNTRs, NRTIs, NRTIs
13
Lopinovir, Ritonavir, Tenofovir, Lamividuna, Zidovudina
PIs, PIs, NRTIs, NRTIs, NRTIs
14
Efavirenz, Tenofovir, Lamivudina
NNTRs, NRTIs, NRTIs
15
Lamivudina, Zidovudina, Efavirenz
NRTIs, NRTIs, NNTRs
16
Estavudina, Lamivudina, Nevipirina
NRTIs, NRTIs, NNTRs
17
Ritonavir, Raltegravir, Darunavir, Lamivudina,Tenofovir.
PIs, INIs, PIs, NRTIs, NRTIs
18
Lopinovir, Ritonavir, Tenofovir, Lamividuna, Zidovudina
PIs, PIs, NRTIs, NRTIs, NRTIs
19
Efavirenz, Tenofovir,Lamivudina
NNTRs, NRTIs, NRTIs
NRTIs: nucleoside/nucleotide analogue reverse-transcriptase inhibitors, NNTRs: non-nucleoside analogue reversetranscriptase inhibitors, PIs: protease inhibitors, INIs: integrase inhibitors

The results of BMR and variables related to body composition and physical fitness are shown in
table 3. No statistically significant differences were observed to BMR and body composition.
With regard to evaluations of muscle strength and cardiorespiratory fitness, patients obtained
statistically significant gains post-CPT for muscle strength and VO2max (Table 3).
Table 3. Body composition, basal metabolic rate and physical fitness before and after combined physical training
among people living with HIV/AIDS.
Parameter
Pre-CPT
Post-CPT
p-value
Body mass (kg)
70.9 ± 18.2
70.6 ± 17.9
0.535
BMI [kg. (m2)-1]
26.7 ± 8.0
26.5 ± 8.0
0.455
Fat mass (%)
30.2 ± 11.3
30.5 ± 11.3
0.531
Lean mass (%)
69.8 ± 11.3
69.5 ± 11.4
0.599
BMR (kcal)
1438.9 ± 227.8
1437.6 ± 222.7
0.712
*
Bench press (kg)
26.9 ± 13.9
31.9 ± 15.5
< 0.001
Leg press (kg)
176.6 ± 72.6
201.9 ± 79.7*
< 0.001
*
Biceps curl (kg)
21.3 ± 8.1
24.4 ± 9.0
< 0.001
-1
-1
*
VO2max (ml.kg .min )
23.7 ± 3.2
29.2 ± 5.6
< 0.001
VO2max: maximal oxygen uptake; Results are expressed as mean ± standard deviation.
* Statistically significant difference (p < 0.05).
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The pre-post values of irisin (A), BDNF (B) and resting blood lactate (C) levels are presented in
figure 3. Only BDNF presented significantly higher values post-CPT (p < 0.001). In addition, there
was a positive correlation between irisin and blood lactate (r = 0.55, p < 0.05) pre-CPT; on the
other hand, there was no correlation with other variables, regardless of the moment analyzed.

Figure 3. Serum concentrations of irisin, BDNF, and resting blood lactate Serum concentrations of irisin (A), BDNF
(B), and resting blood lactate (C), in people living with HIV/AIDS before (pre) and after (post) combined physical
training (CPT). Results are expressed as mean ± standard deviation. * Statistically significant difference (p <0.05).

Lastly, the Cluster analysis provided evidence that the group that presented higher values of
irisin also displays higher resting blood lactate values (Table 4).
Table 4. Values of irisin and resting blood lactate after Cluster analysis.
Variable
Higher Irisin Group
Smaller Irisin Group
-1
Irisin (ng.mL )
203.73 ± 34.74
68.47 ± 35.34*
Blood lactate (mmol.L-1)
3.65 ± 0.69
2.82 ± 0.59*
Results are expressed as mean ± standard deviation. * Statistically significant difference (p < 0.05).

p-value
< 0.001
0.02

DISCUSSION
The present investigation observed changes in plasma concentrations of BDNF, irisin and
resting blood lactate as well as analyzed the correlation between these biomarkers in PLWHA
who completed an 8-week combined physical training program. The main results showed an
increase in BDNF levels as well as an improvement in functional parameters (oxygen
consumption and muscle strength) post-CPT. In addition, there was a positive correlation
between irisin and blood lactate, where individuals with higher levels of irisin showed higher
concentrations of resting blood lactate.
Increase of BDNF: It is known that physical exercise promotes numerous health benefits, and in
PLWHA, due to the presence or risk of neurological and metabolic changes it becomes essential,
because regular exercise can ensure benefits to many systems including the improvement
and/or maintenance of muscle mass, immune system, blood glucose, lipid profile, and cognitive
function (20). In the present study, the levels of BDNF were higher post-CPT, suggesting that
there was a modulation important, may serve as protection against the onset of Alzheimer's
disease, and of psychiatric disorders such as depression common alterations in this population.
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As well as, some authors suggest that concentration of BDNF it can serve as an instrument to
monitor the HIV-Associated Dementia and neurocognitive diseases associated with HIV
(HAND) (18, 31), we suggest that the practice of combined exercise can be part of the daily
routine of people living with HIV.
In a study performed with an animal model, increased secretion of BDNF accompanied by
increasing neurogenesis was observed as well as decreased neuritis post-endurance training (6).
These findings are important because PLWHA present lower levels of BDNF if compared to
healthy individuals, strengthening our initial hypothesis.
It is worth mentioning that our aim was not to evaluate the cognitive function of the participants,
but to verify the concentrations of BDNF as well as its response to CPT. Thus, it is not possible
to say whether there was an improvement in cognitive function of our participants, which
would be confirmed by means of specialized tests, such as the mini-exam of the mental state
(36). However, despite the results related to BDNF being positive, future studies are needed to
examine the pro-BDNF and mad-BDNF isoforms since the binding of mad-BDNF to its
membrane receptor (tyrosine kinase B (TrkB)) is needed for effective action on hippocampal
plasticity and memory formation (21).
Maintenance of hyperlactatemia: It is known that hyperlactatemia, commonly observed in
PLWHA, is related to NRTIs, which can cause mitochondrial dysfunction (22). The patients of
the present study displayed high resting blood lactate levels pre- and post-CPT, even with a
significant improvement in functional parameters (muscle strength and cardiorespiratory
fitness). Usually, the rationale for increases in resting blood lactate is based on the failure of
oxidative phosphorylation due to mutation and the deterioration of mitochondrial DNA. The
inhibition of the enzyme DNA polymerase g changes the replication of mitochondrial DNA,
which is an encoder of subunits of the respiratory chain enzyme complex (3). To elucidate this
question, further analysis of specific biomarkers (e.g. oxidative enzymes [expression and/or
activity], and UCPs) is necessary in order to clarify mitochondrial behavior, specifically in
PLWHA using ART, as well as the response of these biomarkers to CPT.
Irisin and HIV- The Need for Further Studies: In our study, there was no change in the levels of
irisin post-CPT, and in the only other study that determined the concentration of irisin in
PLWHA subjected to physical training (37); on the other hand, the values of this peptide in this
population compared to healthy participants with similar characteristics considering age, BMI
and resting energy expenditure were higher. Interestingly, another work, which corroborated
our findings, showed no change in the levels of irisin 48 hours after the last session of physical
training (33).
It is important to note that changes in irisin levels have been observed, in healthy participants,
when blood sampling is performed immediately after and/or a few hours after the last training
session (14), which did not occur in the present study. Another factor that may have contributed
to this result may have been the time of training applied (8 weeks), which was relatively short.
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The correlation between irisin and resting blood lactate pre-CPT was positive, as well as the
Cluster analysis results denoting a possible relation between these metabolites. Hypothetically,
we suggest that the increased oxidative stress, induced by ART and HIV infection itself, seems
to be an influencer of this finding. This hypothesis is strengthened by the several results found
in the literature (2, 5, 19, 28, 41), which shown increased oxidative stress via mitochondrial
dysfunction and a concomitant increase in the expression of both PGC1-α and FNDC-5, causing
the elevation of plasma irisin levels. These relationships between irisin and oxidative stress are
suggested not only by mitochondrial dysfunctions (16, 36) but also as a protective and antioxidant effect, since this peptide has been shown to be important in neutralizing free radicals
and improving redox balance (2, 5, 28).
Some studies have shown the correlation between irisin and BDNF at the molecular level. In an
interesting study (39), it was reported that stimulation of the PGC-1α/FNDC5 pathway by
exercise increased the expression and secretion of irisin. Taking into consideration that this same
pathway triggers a cascade of signaling which will stimulate an unknown transcription factor
and, mainly, the expression of BDNF (40), it is possible to suggest that physical exercise is a
potent inducer of this neurotrophic factor, via irisin, in the healthy people.
However, our results did not show a correlation between plasma levels of irisin, and BDNF,
even with increased BDNF; and this result confirms the findings of other studies (23) conducted
in healthy young individuals. On the contrary, a study performed with athletes found a positive
correlation (6). Taken together, these results show that the population studied as well as the
fitness level of the subject can be the determining factor for the discrepancy between the results
for irisin and BDNF here reported.
The present study had, at the beginning of the activities, with a total number of 25 participants,
however, reached the final with nineteen participants and did not have a control group. The
reasons for the discontinuity in the research were: lack of willingness of the participants to
participate in the training sessions; family problems; motorcycle accident (figure 1). This sample
loss characterizes the limitations of our work, although studies with this population normally
confirm this difficulty (11, 15). In addition, it is known that the exclusion of participants in order
to form a control group may compromise the participation of all participants involved (11, 15).
Conclusion: Combined physical training program increased basal plasma concentrations of
BDNF as well as improved muscle strength and cardiorespiratory fitness among PLWHA. There
was a correlation between irisin and resting blood lactate levels before the CPT was initiated; in
addition, resting blood lactate values were higher in the group with the highest value of irisin.
There was no correlation between the plasma levels of irisin and BDNF. In relation to
concentration BDNF in PLWHA, this finding suggests that increased concentration of BDNF
may be associated with decreased chances of developing cognitive disorders and/or HIVassociated dementia. Future studies can be carried out with a focus on the molecular and
mechanistic relation between BDNF, irisin and resting blood lactate, in particular in PLWHA.
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